| First Author | Durrant DM | Year | 2009 |
| Journal | J Immunol | Volume | 183 |
| Issue | 8 | Pages | 5293-300 |
| PubMed ID | 19783683 | Mgi Jnum | J:153827 |
| Mgi Id | MGI:4366384 | Doi | 10.4049/jimmunol.0803109 |
| Citation | Durrant DM, et al. (2009) Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol 183(8):5293-300 |
| abstractText | Dysfunctional expression of T-bet, a transcription factor that is critical for IFN-gamma production, has been implicated in the development of asthma. To investigate in detail the mechanisms responsible for exacerbated disease in the absence of T-bet expression, BALB/c wild-type (WT) and T-bet(-/-) mice were used in a murine model of OVA-induced allergic lung inflammation. Following OVA challenge, T-bet(-/-) mice displayed increased histological inflammation in the lungs as well as greater thickening of the bronchiole linings, increased numbers of eosinophils and neutrophils in the lung, and enhanced airway hyperresponsiveness, compared with WT mice. However, the production of Th2 cytokines in T-bet(-/-) mice did not appear to be significantly greater than in WT mice. Interestingly, a marked increase in the levels of the proinflammatory cytokine IL-17 was observed in T-bet(-/-) mice. Neutralization of pulmonary IL-17 in T-bet(-/-) mice by anti-IL-17 mAb treatment during OVA challenge resulted in decreased levels of neutrophilic infiltration into the airways and decreased airway inflammation, essentially reversing the development of allergic asthma development. These findings indicate that IL-17 is a key mediator of airway inflammation in the absence of T-bet. The results of this study suggest a possible target for therapeutic intervention of human asthma. |
